Clinicians' perspectives on supporting individuals with severe anorexia nervosa in specialist eating disorder intensive treatment settings.
Anorexia nervosa
Clinicians
Day patient
Eating disorders
Healthcare professionals
Inpatient
Intensive treatment
Qualitative research
Journal
Journal of eating disorders
ISSN: 2050-2974
Titre abrégé: J Eat Disord
Pays: England
ID NLM: 101610672
Informations de publication
Date de publication:
06 Jan 2022
06 Jan 2022
Historique:
received:
11
09
2021
accepted:
16
12
2021
entrez:
7
1
2022
pubmed:
8
1
2022
medline:
8
1
2022
Statut:
epublish
Résumé
Admissions to intensive treatment (i.e., inpatient [IP] and/or day patient [DP]) for individuals with severe anorexia nervosa (AN) are common. Growing literature indicates potential risks and benefits of each intensive treatment approach; however, existing research has focused on patient and carer perspectives of these treatments. Also, there is scant empirical evidence available for guiding the parameters of intensive treatments for AN. We therefore explored clinicians' perspectives and experience of supporting adults with severe AN in intensive settings. We conducted twenty one semi-structured interviews with clinicians who deliver intensive treatments (i.e., IP and/or DP) for individuals with severe AN across four specialist Eating Disorder Services in the United Kingdom between May 2020 and June 2021. We asked clinicians about their views and experiences of supporting individuals with severe AN in intensive treatment settings and the challenges and opportunities associated with IP and DP treatment. Data were analysed using reflexive thematic analysis supported by NVivo software. Five broad and interrelated themes were identified: (1) Intensive Support; (2) The Severity of Patients' Illnesses; (3) Hope and Recovery; (4) Which Treatment When; (5) Limited Resources; and (6) Carer Burden. We identified various similarities between the two intensive treatment approaches, including the value of intensive and multidisciplinary support and carer involvement, and the challenge of managing complex and unique needs in resource-limited intensive settings. We also found differences in the relationship of treatment to patients' home environments, the necessity of patient motivation, and the management of risk. Both intensive treatment settings are valued by clinicians; however, there are unique challenges and opportunities for supporting individuals with severe AN within each. Our findings suggest DP treatment may be used as an alternative to IP treatment for individuals with severe AN. However, clear questions remain over which intensive treatment setting is best suited to which patient when and should be the focus of future research. Some people with anorexia nervosa will need intensive treatment (e.g., inpatient and day patient treatment) during the course of their illness. We interviewed twenty-one clinicians working in Specialist Eating Disorder Services to explore their views on supporting people with severe anorexia nervosa in inpatient and day patient services and about the perceived advantages and disadvantages of these. We analysed the transcripts of these interviews using thematic analysis. We identified similarities between the two intensive treatment approaches. These included the value of intensive and multidisciplinary support, the importance of carer involvement, and the challenge of managing patient’s complex and unique needs in services with limited resources. We also found differences between inpatient and day patient treatment. These included how treatment relates to patients’ home environments, the importance of patient motivation, and managing risk. Day patient treatment may be an alternative to inpatient treatment for people with severe anorexia nervosa. Future research should investigate which intensive treatment setting is best suited to which patient and when.
Sections du résumé
BACKGROUND
BACKGROUND
Admissions to intensive treatment (i.e., inpatient [IP] and/or day patient [DP]) for individuals with severe anorexia nervosa (AN) are common. Growing literature indicates potential risks and benefits of each intensive treatment approach; however, existing research has focused on patient and carer perspectives of these treatments. Also, there is scant empirical evidence available for guiding the parameters of intensive treatments for AN. We therefore explored clinicians' perspectives and experience of supporting adults with severe AN in intensive settings.
METHODS
METHODS
We conducted twenty one semi-structured interviews with clinicians who deliver intensive treatments (i.e., IP and/or DP) for individuals with severe AN across four specialist Eating Disorder Services in the United Kingdom between May 2020 and June 2021. We asked clinicians about their views and experiences of supporting individuals with severe AN in intensive treatment settings and the challenges and opportunities associated with IP and DP treatment. Data were analysed using reflexive thematic analysis supported by NVivo software.
RESULTS
RESULTS
Five broad and interrelated themes were identified: (1) Intensive Support; (2) The Severity of Patients' Illnesses; (3) Hope and Recovery; (4) Which Treatment When; (5) Limited Resources; and (6) Carer Burden. We identified various similarities between the two intensive treatment approaches, including the value of intensive and multidisciplinary support and carer involvement, and the challenge of managing complex and unique needs in resource-limited intensive settings. We also found differences in the relationship of treatment to patients' home environments, the necessity of patient motivation, and the management of risk.
CONCLUSIONS
CONCLUSIONS
Both intensive treatment settings are valued by clinicians; however, there are unique challenges and opportunities for supporting individuals with severe AN within each. Our findings suggest DP treatment may be used as an alternative to IP treatment for individuals with severe AN. However, clear questions remain over which intensive treatment setting is best suited to which patient when and should be the focus of future research.
Some people with anorexia nervosa will need intensive treatment (e.g., inpatient and day patient treatment) during the course of their illness. We interviewed twenty-one clinicians working in Specialist Eating Disorder Services to explore their views on supporting people with severe anorexia nervosa in inpatient and day patient services and about the perceived advantages and disadvantages of these. We analysed the transcripts of these interviews using thematic analysis. We identified similarities between the two intensive treatment approaches. These included the value of intensive and multidisciplinary support, the importance of carer involvement, and the challenge of managing patient’s complex and unique needs in services with limited resources. We also found differences between inpatient and day patient treatment. These included how treatment relates to patients’ home environments, the importance of patient motivation, and managing risk. Day patient treatment may be an alternative to inpatient treatment for people with severe anorexia nervosa. Future research should investigate which intensive treatment setting is best suited to which patient and when.
Autres résumés
Type: plain-language-summary
(eng)
Some people with anorexia nervosa will need intensive treatment (e.g., inpatient and day patient treatment) during the course of their illness. We interviewed twenty-one clinicians working in Specialist Eating Disorder Services to explore their views on supporting people with severe anorexia nervosa in inpatient and day patient services and about the perceived advantages and disadvantages of these. We analysed the transcripts of these interviews using thematic analysis. We identified similarities between the two intensive treatment approaches. These included the value of intensive and multidisciplinary support, the importance of carer involvement, and the challenge of managing patient’s complex and unique needs in services with limited resources. We also found differences between inpatient and day patient treatment. These included how treatment relates to patients’ home environments, the importance of patient motivation, and managing risk. Day patient treatment may be an alternative to inpatient treatment for people with severe anorexia nervosa. Future research should investigate which intensive treatment setting is best suited to which patient and when.
Identifiants
pubmed: 34991715
doi: 10.1186/s40337-021-00528-z
pii: 10.1186/s40337-021-00528-z
pmc: PMC8733908
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3Subventions
Organisme : National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme
ID : 17/123/03
Informations de copyright
© 2021. The Author(s).
Références
Eur Eat Disord Rev. 2021 May;29(3):371-392
pubmed: 33548148
Dtsch Arztebl Int. 2011 Oct;108(40):678-85
pubmed: 22114627
Behav Modif. 2004 Nov;28(6):831-53
pubmed: 15383688
J Health Psychol. 2016 Jan;21(1):16-27
pubmed: 24505059
Aust N Z J Psychiatry. 2002 Dec;36(6):717-32
pubmed: 12406114
J Eat Disord. 2019 Jun 17;7:20
pubmed: 31236275
Am J Bioeth. 2021 Jul;21(7):46-56
pubmed: 33370215
Eur Eat Disord Rev. 2020 Nov;28(6):750-765
pubmed: 32964575
Actas Esp Psiquiatr. 2020 Jan;48(1):19-27
pubmed: 32297648
Clin Child Psychol Psychiatry. 2020 Jan;25(1):16-32
pubmed: 31648525
Lancet Psychiatry. 2015 Dec;2(12):1099-111
pubmed: 26514083
Br J Psychiatry. 2005 Nov;187:398-400
pubmed: 16260812
Eur Eat Disord Rev. 2021 May;29(3):306-315
pubmed: 33629403
Lancet. 2014 Apr 5;383(9924):1222-9
pubmed: 24439238
Clin Psychol Psychother. 2019 Nov;26(6):707-716
pubmed: 31368595
Int J Eat Disord. 2020 Dec;53(12):1941-1951
pubmed: 32918314
Clin Psychol Psychother. 2017 Jan;24(1):103-125
pubmed: 26472481
BJPsych Open. 2019 Jul 12;5(4):e59
pubmed: 31530301
Front Psychiatry. 2021 Feb 25;12:641861
pubmed: 33716836
Eur Eat Disord Rev. 2017 Nov;25(6):432-450
pubmed: 28967161
Int J Eat Disord. 2020 Aug;53(8):1209-1218
pubmed: 32453448
Nutrients. 2021 Apr 13;13(4):
pubmed: 33924294
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
JAMA Psychiatry. 2021 Jun 1;78(6):591-592
pubmed: 33625500
Am J Bioeth. 2021 Jul;21(7):57-59
pubmed: 34152907
Aust Occup Ther J. 2018 Apr;65(2):98-106
pubmed: 29270987
Eur Eat Disord Rev. 2010 Sep-Oct;18(5):390-8
pubmed: 20821740
Front Psychiatry. 2021 May 28;12:653482
pubmed: 34122177
J Eat Disord. 2018 Nov 1;6:32
pubmed: 30410759
Br J Psychiatry. 2011 Jul;199(1):5-7
pubmed: 21719874
Int J Eat Disord. 2002 Mar;31(2):105-17
pubmed: 11920973
BJPsych Open. 2019 Jan;5(1):e6
pubmed: 30762506
Eat Disord. 2017 Jul-Sep;25(4):279-296
pubmed: 28448243
J Eat Disord. 2017 Nov 1;5:34
pubmed: 29118983
Lancet. 2020 Mar 14;395(10227):899-911
pubmed: 32171414
Int Rev Psychiatry. 2019 Jun;31(4):382-390
pubmed: 30916597
J Health Psychol. 2015 Jan;20(1):27-36
pubmed: 23933950
BJPsych Bull. 2021 Sep 06;:1-7
pubmed: 34486966
J Health Psychol. 2017 Apr;22(5):582-594
pubmed: 26446375
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
Int J Ment Health Nurs. 2014 Feb;23(1):60-8
pubmed: 23413943
Eur J Gen Pract. 2018 Dec;24(1):120-124
pubmed: 29202616
Curr Psychiatry Rep. 2016 Feb;18(2):16
pubmed: 26781554
Perspect Clin Res. 2013 Jul;4(3):192
pubmed: 24010063
Eur Eat Disord Rev. 2011 Jul-Aug;19(4):296-302
pubmed: 21714039
Eur Eat Disord Rev. 2011 Jul-Aug;19(4):289-95
pubmed: 21394837